RENIN INHIBITORS

Described are compounds which bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with aspartic protease activity. Also described are methods of use of the compounds described herein in ameliorating or treating aspartic protea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KNAPP-REED, BETH, A, SEMUS, SIMON, ZHANG, JING, HOU, XIAOPING, DILLARD, LAWRENCE, W, TICE, COLIN, TRAN, TRITIN, YUAN, JING, GHIRLANDA, DAMIANO, SINGH, SURESH, B, ISHCHENKO, ALEXEY, V, CLAREMON, DAVID, MCGEEHAN, GERARD, XU, ZHENRONG, GHAVIMI-ALAGHA, BAHMAN, LU, QING, KALLANDER, LARA, S, FLAHERTY, PATRICK, T, SIMPSON, ROBERT, D, BALDWIN, JOHN, J, LAWHORN, BRIAN, TERRELL, LAMONT, R, ZHAO, WEI, CACATIAN, SALVACION
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Described are compounds which bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with aspartic protease activity. Also described are methods of use of the compounds described herein in ameliorating or treating aspartic protease related disorders in a subject in need thereof. L'invention concerne des composés qui se fixent aux protéases aspartiques pour inhiber leur activité. Ils sont utiles dans le traitement ou l'amélioration des symptômes de maladies associées à l'activité des protéases aspartiques. L'invention concerne également des méthodes d'utilisation des composés décrits dans la présente demande pour améliorer ou traiter les symptômes de troubles liés aux protéases aspartiques chez un sujet nécessitant un tel traitement.